A phase II, single-arm trial of adebrelimab plus nab-paclitaxel and carboplatin as first-line therapy for advanced thymic carcinoma: Interim efficacy and safety results. This is an ASCO Meeting ...
Carcinoid tumor of the bronchus and lung: A nationwide cross-sectional study. This is an ASCO Meeting Abstract from the 2023 ASCO Annual Meeting I. This abstract does not include a full text component ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results